Shares of GE Vernova (GEV) returned 66.5% in the twelve months to October 13, 2026, outpacing the 20.5% return for the S&P 500. During that period, orders consistently increased at the company's Power ...

GE Vernova’s stock has slipped into a bear market this year, falling from its year-to-date high of $1,193 to $938. The ...

GE Vernova stock has skyrocketed since its debut two and a half years ago.

Target Price (Mid): ~$3,720Street Target: ~$1,225Potential Total Return: ~270%Annualized IRR: ~36% / yearWhat Happened?GE ...

GE Vernova's cash outlook just surged while the stock sat still, and that gap between price and reality has analysts lining ...

One generates a quarter of global electricity and carries zero debt. The other is pre-revenue but backed by Meta and Switch.

GE Vernova Inc. is currently listed on NYSE under GEV. One share of GEV stock can currently be purchased for approximately $941.78. Is GE Vernova Inc. (GEV) overvalued or undervalued? GE Vernova ...

GE Aerospace’s engine MRO site in Prestwick, Scotland will receive a £57 million ($75 million) investment for expansion and modernization as the engine OEM looks to bolster its commercial aftermarket ...

The deal expands GE HealthCare’s footprint in radiopharmaceuticals, its fastest-growing segment.

Sofie Biosciences is expected to expand GE HealthCare’s footprint in the radiopharmaceutical industry, helping manufacture ...

GE Healthcare will buy Sofie Biosciences in a $945 million cash deal, giving GE Healthcare U.S. access to a key imaging agent for PET scans.

GE Vernova provides products and services to generate, transfer, and store electricity. The company technology generates about 25% of the world's power for utilities and industrial users. It has ...